Burning Rock IPO (Part I): Burning a Path to Profitability in Next-Gen Cancer Testing
Burning Rock Biotech Ltd (BNR), China’s number one NGS-based cancer therapy selection company has filed for an IPO in the US to raise up to...
345 Views
Burning Rock Biotech IPO: Valuation Insights
Burning Rock Biotech (BNR US) is a precision oncology and early cancer detection company. It is China’s number one NGS-based cancer therapy...
330 Views
Burning Rock (传奇生物) IPO: Sentiment Matters
Burning Rock, a leading precision oncology player in China, started book building to raise up to USD 235 million (including concurrent private...
335 Views
ECM Weekly (7 June 2020) - JD & NetEase HK Bookbuild, Burning Rock & Nongfu Spring Valuation
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong Kong...
349 Views
Burning Rock (燃石医学) Pre-IPO: Thoughts on Valuation
Burning Rock, a leading precision oncology player in China, is aiming to raise USD 100 million via a listing in the US. The company is the number...
489 Views